INTRODUCTION:
Timely administration of corticosteroids reduces RDS of the newborn, IVH, necrotizing enterocolitis, and perinatal mortality. Corticosteroids are optimally effective 1-7 days after the first dose. A single rescue course of steroids may be given at least 1-2 weeks after the initial course. We sought to determine the optimal timing for administration of rescue course corticosteroids in women with PPROM prior to 33 weeks.
METHODS:
This was an IRB-approved retrospective cohort from 2013-2017 of 66 singleton gravidas with PPROM at 23 0/7-32 6/7 weeks. Observing when these women spontaneously labored or underwent indicated delivery, we compared hypothetical strategies for timing of rescue corticosteroids. This included administration of corticosteroids at 1, 2, 3, or 4 weeks after PPROM, versus withholding until spontaneous labor or indicated delivery. A Chi-squared test was used to compare the likelihood of delivery within the optimal window of the first dose of either the initial or rescue corticosteroids.
RESULTS:
The median interval from PPROM to delivery was 6.6 (3.3-16.4) days. Giving rescue corticosteroids 1 week after PPROM had the greatest number of deliveries occurring in the optimal window compared to 2, 3, or 4 weeks. Withholding rescue corticosteroids until spontaneous labor or indicated delivery was statistically less likely to result in deliveries during the optimal window compared to routinely giving corticosteroids 1 week after PPROM (45.5% vs 63.6%, p=0.04).
CONCLUSION:
In women with PPROM prior to 33 weeks, routinely administering rescue course corticosteroids 1 week after PPROM improves the likelihood of delivery within the optimal window for corticosteroid benefit.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.